Yahoo Finance25d
Gilead’s Seladelpar Receives Positive CHMP Opinion for Primary Biliary Cholangitis
Seladelpar Would Provide an Important Treatment Option for People Living with the Rare Liver Disease in the EU – FOSTER CITY, Calif., December 13, 2024--(BUSINESS WIRE)--Gilead Sciences ...
Morningstar25d
Gilead’s Seladelpar Receives Positive CHMP Opinion for Primary Biliary Cholangitis
In addition to Europe, Gilead is working with regulatory authorities on marketing applications for seladelpar in other parts of the world. In August 2024, the FDA granted accelerated approval for ...
PMLiVE18d
Gilead’s seladelpar recommended by CHMP to treat primary biliary cholangitis
Gilead Sciences’ seladelpar has been recommended by the European Medicines Agency’s human medicines committee to treat the ...
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise
Gilead stock rated buy for thriving HIV biz, promising oncology pipeline, and long-term growth potential despite volatility.
Stockhouse25d
Gilead's Seladelpar Receives Positive CHMP Opinion for Primary Biliary Cholangitis
CloseCurlyDoubleQuote; In addition to Europe, Gilead is working with regulatory authorities on marketing applications for seladelpar in other parts of the world. In August 2024, the FDA granted ...
Yahoo Finance25d
Gilead’s Seladelpar Receives Positive CHMP Opinion for Primary Biliary Cholangitis
If Approved by the European Commission, Seladelpar Would Provide an Important Treatment Option for People Living with the Rare Liver Disease in the EU – FOSTER CITY, Calif., December 13, ...
Business Insider25d
Gilead Sciences Says Seladelpar Gets Positive CHMP Opinion For Primary Biliary Cholangitis
(RTTNews) - Gilead Sciences, Inc. (GILD ... adopted a positive opinion recommending seladelpar for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid ...